These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 16414207)

  • 1. Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation.
    Chen Y; Trotti A; Coleman CN; Machtay M; Mirimanoff RO; Hay J; O'brien PC; El-Gueddari B; Salvajoli JV; Jeremic B
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1442-51. PubMed ID: 16414207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety in radiation oncology: the role of international initiatives by the International Atomic Energy Agency.
    Abdel-Wahab M; Rosenblatt E; Holmberg O; Meghzifene A
    J Am Coll Radiol; 2011 Nov; 8(11):789-94. PubMed ID: 22051464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency.
    Davidson SE; Trotti A; Ataman OU; Seong J; Lau FN; da Motta NW; Jeremic B
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1218-21. PubMed ID: 17689027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological basis of a comprehensive grading system for the adverse effects of cancer treatment.
    Williams J; Chen Y; Rubin P; Finkelstein J; Okunieff P
    Semin Radiat Oncol; 2003 Jul; 13(3):182-8. PubMed ID: 12903008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.
    van der Laan HP; van den Bergh A; Schilstra C; Vlasman R; Meertens H; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1138-45. PubMed ID: 17931794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology.
    Bentzen SM
    Nat Rev Cancer; 2006 Sep; 6(9):702-13. PubMed ID: 16929324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of the pathological changes induced by radiotherapy in normal tissues.
    Rezvani M
    J Pharm Pharmacol; 2008 Aug; 60(8):1037-48. PubMed ID: 18644196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the possibility of unique molecular, biological, and tissue effects with hypofractionated radiotherapy.
    Story M; Kodym R; Saha D
    Semin Radiat Oncol; 2008 Oct; 18(4):244-8. PubMed ID: 18725111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators.
    Movsas B; Vikram B; Hauer-Jensen M; Moulder JE; Basch E; Brown SL; Kachnic LA; Dicker AP; Coleman CN; Okunieff P
    Clin Cancer Res; 2011 Jan; 17(2):222-8. PubMed ID: 21047979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for the future of translational radiobiology research: a Canadian perspective.
    Bristow RG;
    Radiother Oncol; 2004 Feb; 70(2):159-64. PubMed ID: 15028402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using biological markers to predict risk of radiation injury.
    Fleckenstein K; Gauter-Fleckenstein B; Jackson IL; Rabbani Z; Anscher M; Vujaskovic Z
    Semin Radiat Oncol; 2007 Apr; 17(2):89-98. PubMed ID: 17395039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further radiobiologic modeling of palliative radiotherapy: use of virtual trials.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):221-9. PubMed ID: 17707276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care.
    Ishikura S
    Jpn J Clin Oncol; 2008 Nov; 38(11):723-9. PubMed ID: 18952706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology for the radiation oncologist: the 5Rs of radiobiology meet the hallmarks of cancer.
    Harrington K; Jankowska P; Hingorani M
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):561-71. PubMed ID: 17591437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiation biology: major advances and perspectives for radiotherapy].
    Joubert A; Vogin G; Devic C; Granzotto A; Viau M; Maalouf M; Thomas C; Colin C; Foray N
    Cancer Radiother; 2011 Aug; 15(5):348-54. PubMed ID: 21683640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoprotection for radiation-associated normal tissue injury.
    Mao J; Fatunase OA; Marks LB
    Cancer Treat Res; 2008; 139():307-27. PubMed ID: 18236722
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement tools for gastrointestinal symptoms in radiation oncology.
    West CM; Davidson SE
    Curr Opin Support Palliat Care; 2009 Mar; 3(1):36-40. PubMed ID: 19262387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases.
    Chow E; Hoskin P; Mitera G; Zeng L; Lutz S; Roos D; Hahn C; van der Linden Y; Hartsell W; Kumar E;
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1730-7. PubMed ID: 21489705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A future vision of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking for Asia and the Pacific and Latin American regions.
    Morales Pedraza J
    Cell Tissue Bank; 2009 May; 10(2):191-6. PubMed ID: 18575960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.